Outlook Therapeutics (OTLK) Earnings Date, Estimates & Call Transcripts $4.93 -0.10 (-1.99%) (As of 11/25/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Outlook Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Outlook Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataOTLK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.OTLK Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry Research"This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined"What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?Click here to see why experts and insiders may be preparing for the biggest financial crisis of the Outlook Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243-$0.05-$0.04-$0.05Q2 20243-$1.28-$0.42-$0.88Q3 20243-$1.09-$0.64-$0.86Q4 20243-$0.89-$0.76-$0.84FY 202412-$3.31-$1.86-$2.62Q1 20251-$0.99-$0.99-$0.99Q2 20251-$0.58-$0.58-$0.58Q3 20251-$0.43-$0.43-$0.43Q4 20251-$0.24-$0.24-$0.24FY 20254($2.24)($2.24)($2.24) Outlook Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 12/27/2024(Estimated)------- 8/14/2024Q3 2024-$1.06-$0.83+$0.23-$0.77--5/15/2024Q2 2024-$0.88-$1.55 -$0.67$4.91-- 2/14/2024Q1 2024-$1.00-$0.80+$0.20-$0.04-- 12/22/2023Q4 2023-$1.00-$1.00--$0.05-- 8/14/2023Q3 2023-$0.80-$1.60 -$0.80-$0.08-- 5/15/2023Q2 2023-$1.20-$0.60+$0.60-$0.03-- "This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined" (Ad)What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?Click here to see why experts and insiders may be preparing for the biggest financial crisis of the 2/14/2023Q1 2023-$0.80-$1.60 -$0.80-$0.08-- Outlook Therapeutics Earnings - Frequently Asked Questions When is Outlook Therapeutics's earnings date? Outlook Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, December 27th, 2024 based off last year's report dates. Learn more on OTLK's earnings history. How much profit does Outlook Therapeutics generate each year? Outlook Therapeutics (NASDAQ:OTLK) has a recorded net income of -$58.98 million. OTLK has generated -$10.70 earnings per share over the last four quarters. What is Outlook Therapeutics's EPS forecast for next year? Outlook Therapeutics's earnings are expected to grow from ($3.84) per share to ($2.21) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Foghorn Therapeutics Earnings Verve Therapeutics Earnings Xeris Biopharma Earnings Ginkgo Bioworks Earnings Aura Biosciences Earnings Alumis Earnings Tango Therapeutics Earnings KalVista Pharmaceuticals Earnings Aquestive Therapeutics Earnings Akebia Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report "This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined" (Ad)What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?Click here to see why experts and insiders may be preparing for the biggest financial crisis of the This page (NASDAQ:OTLK) was last updated on 11/26/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | Sponsored9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be wor...StockEarnings | SponsoredFormer Trump advisor issues urgent warningElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outlook Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Outlook Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OTLK Stock Alerts